Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: the impact of comorbidity and demographics on initial choice. (2014)
Attributed to:
MICA: Centre for the Improvement of Population Health through E-health Research (CIPHER)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0084835
PubMed Identifier: 24392158
Publication URI: http://europepmc.org/abstract/MED/24392158
Type: Journal Article/Review
Volume: 9
Parent Publication: PloS one
Issue: 1
ISSN: 1932-6203